Equine/Camelid

Equine/Camelid Stem Cells

Mesenchymal stem cell therapies use the regenerative and immunomodulatory properties of UCT-WJ-MSCs to improve prevention, management, and repair of musculoskeletal and chronic conditions in horses and camels, advancing welfare and performance in high-value animals.

Overview

Overview

Akira Horse/Camel MSCs are UCT-WJ-MSCs formulated for equine and camelid applications — the largest and most high-value segment of veterinary regenerative medicine. Performance horses (racehorses, showjumpers, polo horses) and racing camels represent high-value applications where the economics of regenerative medicine are most compelling. UCT-derived MSCs outperform the standard adipose or bone marrow sources typically used in equine practice, providing superior anti-inflammatory potency and tissue regeneration capacity without invasive collection procedures.

Product Options MSC
10M cells/2mL
25M cells/5mL
Neural: 10M cells/2mL
Neural: 25M cells/5mL

Applications

Large Animal Applications

  • Tendonitis & Suspensory Ligament Injuries — biologic augmentation of tendon healing
  • Osteoarthritis & Joint Degeneration — intra-articular regenerative injection
  • Wound Healing — soft tissue injury recovery
  • Performance Optimization — reducing oxidative stress and tissue fatigue
  • Respiratory Conditions — equine asthma, recurrent airway obstruction

Neural

Horse/Camel Neural Stem Cells

Akira Horse/Camel Neural Stem Cells represent a pioneering product in equine neurology. These cells address spinal cord injuries (Wobbler syndrome, EPM sequelae, traumatic injury), head trauma recovery, and hindlimb ataxia — conditions with no established regenerative treatments in equine practice. Immune-privileged allogeneic delivery without rejection concerns enables practical clinical application in diverse large animal settings.